[1]Souza HP, Lima-Salgado T, da CNLM. Toll-like receptors in sepsis: a tale still being told[J]. Endocr Metab Immune Disord Drug Targets, 2010, 10(3):285-291.
[2]李成荣.脓毒症免疫功能紊乱及免疫调节治疗[J].临床儿科杂志, 2010, 28(1):13-17.
[3]Lang PO, Aspinall R. Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response[J]. Nutrients, 2015, 7(3):2044-2060.
[4]刘军, 张鹏,于晴, 等.一种高效的小鼠肺单细胞悬液制备方法的研究[J].东南大学学报, 2012, 31(2):143-146.
[5]Hirsiger S, Simmen HP, Werner CM, et al. Danger signals activating the immune response after trauma[J]. Mediators Inflamm, 2012, 2:189-194.
[6]Schlitzer A, Ginhoux F. Organization of the mouse and human DC network[J]. Curr Opin Immunol, 2014, 26:90-99.
[7]陆江阳,李志宏,王晓虹,等.脾脏树突状细胞在多器官功能障碍综合征中的变化及意义[J].中国危重病急救医学, 2006,18(1):24-27.
[8]Kempker JA, Tangpricha V, Ziegler TR, et al. Vitamin D in sepsis:from basic science to clinical impact[J]. Crit Care, 2012, 16(4):316.
[9]Hewison M. Vitamin D and immune function: an overview[J]. Proc Nutr Soc, 2012, 71(1):50-61.
[10]Konijeti GG, Arora P, Boylan MR, et al. Vitamin Dsuplementation modulatea T cell-mediated immunity in humans:results from a randamized cantrd trial[J]. J Clin Endocrinol Metab, 2016, 101(20):533-538.
[11]Adorini L, Giarratana N, Penna G. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells[J]. Semin Immunol, 2004, 16(2):127-134.
[12]Hackstein H, Thomson AW. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs[J]. Nat Rev Immunol, 2004, 4(1):24-34.
[13]Quraishi SA. De Pascale G, Needleman JS, et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial[J]. Crit Care Med, 2015, 43(9):1928-1937.
[14]徐俊,杨家东,陈剑,等.维生素D对脓毒症大鼠血清血管性血友病因子裂解蛋白酶表达的影响[J]. 中国急救医学, 2015, 35(12):1079-1082.
[15]Ferreira GB, Overbergh L, Verstuyf A, et al. 1,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: A comparison dose-titration study[J]. J Steroid Biochem Mol Biol, 2013, 136:160-165.
[16]Penna G, Adorini L. 1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation,and survival of dendritic cells leading to impaired alloreactive T cell activation[J]. J Immunol, 2000, 164(5): 2405-2411.
[17]Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes[J]. Ann NY Acad Sci, 2003, 987:258-261.
[18]Cantorna MT, Snyder L, Lin YD, et al. Vitamin D and 1,25(OH)2D regulation of T cells[J].Nutrients, 2015, 7(4):3011-3021.
[19]Ryynanen J, Carlberg C. Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells[J]. PLos One, 2013, 8(10): e78170.